![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Pharmaceuticals Reports Second Quarter 2014 Results
August 07, 2014 16:01 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Pharmaceuticals Initiates Pivotal Phase 2/3 Clinical Trial for SD-809 in Tardive Dyskinesia
July 17, 2014 07:00 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., July 17, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Announces Completion of Follow on Offering and Exercise of Underwriters' Option to Purchase Additional Shares
July 16, 2014 16:00 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Announces Pricing of Follow On Offering
July 11, 2014 08:00 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., July 11, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Pharmaceuticals Announces Data From Interim Analysis of ARC-HD Switch Trial Demonstrating Clinical Activity of SD-809
June 23, 2014 16:40 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., June 23, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex to Present at Jefferies Global Healthcare Conference
May 28, 2014 08:00 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., May 28, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...
![Auspex Pharmaceuticals logo](/news-release/logo/309081/0/309081.jpg?lastModified=12%2F09%2F2016%2023%3A04%3A24&size=2)
Auspex Pharmaceuticals Reports 2014 First Quarter Results
May 13, 2014 16:00 ET
|
Auspex Pharmaceuticals, Inc.
LA JOLLA, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- Auspex Pharmaceuticals, Inc. (Nasdaq:ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines...